DAWN™
DATABASE OF AUTOIMMUNE & WOMEN’S NETWORKS
DAWN™ is a living, adaptive global intelligence map of immuno-endocrine terrain built from CYNAERA’s pattern-detection engines, prevalence corrections, and flare forecasting systems. DAWN™ transforms symptom data into system intelligence, enabling earlier detection, safer care pathways, and predictive modeling across autoimmune, hormonal, and infection-associated conditions.
WHAT DAWN™ IS
DAWN™ is the first integrated platform to model the interactions between hormones, immune function, environment, and chronic illness across the life course. It converts fragmented clinical observations into a unified terrain framework that reveals patterns traditional systems cannot see.
DAWN™ is:
-
The first dynamic autoimmune atlas
-
The first menstrual-immune modeling platform
-
The first hormone-immune-environment network engine
-
The first system to unify Long COVID, ME/CFS, MCAS, EDS, POTS, PMDD, endometriosis, adenomyosis, PCOS, autoimmune flares, and maternal health trajectories
DAWN™ turns women’s symptoms into signals, signals into systems, and systems into predictive models.
WHY DAWN™ MATTERS
Autoimmune and hormone-linked conditions are among the most under-recognized drivers of disability, healthcare cost, and workforce attrition worldwide. Traditional systems treat these conditions as isolated diagnoses rather than interconnected terrain responses.
DAWN™ enables institutions to:
-
Detect cross-condition patterns earlier
-
Reduce diagnostic delay
-
Improve care coordination
-
Anticipate flare risk
-
Quantify regional burden
-
Design targeted policy and resource allocation
By modeling the immune-endocrine terrain as an integrated system, DAWN™ converts chronic illness from an unpredictable crisis into a measurable, preventable risk.
CONDITIONS & TRAJECTORIES UNIFIED
DAWN™ models cross-condition interactions across:
-
Long COVID
-
ME/CFS
-
MCAS
-
Dysautonomia
-
Endometriosis
-
Adenomyosis
-
Autoimmune diseases
-
Maternal health
-
Menopause immune shifts
-
EDS & connective tissue disorders
The platform captures shared drivers such as immune dysregulation, hormonal fluctuation, autonomic instability, environmental load, and post-viral triggers.
WHY DAWN™ CHANGES THE PUBLIC HEALTH LANDSCAPE
Public health systems were built to track outbreaks, not terrain. Autoimmune and hormone-linked conditions develop gradually, fluctuate over time, and are shaped by endocrine cycles, environmental exposure, and delayed immune responses. Because they do not fit acute surveillance models, they remain undercounted, misclassified, and excluded from planning and funding decisions.
DAWN™ introduces a terrain-based intelligence layer that detects destabilization signals before diagnosis, aggregates burden across conditions, and models life-stage risk windows such as pregnancy, postpartum, and perimenopause. This enables agencies to anticipate service demand, align maternal and disability supports, and prevent avoidable escalation into emergency care, workforce loss, and long-term system costs.
By making previously invisible patterns measurable, DAWN™ allows public health leaders to move from reactive spending to prevention-focused planning, aligning environmental policy, healthcare delivery, and social supports with how chronic illness actually unfolds in real populations.
THE EVE RESEARCH PROJECT: REAL-WORLD PATTERN LAYER
The Eve Research Project operates as a real-world research layer within the broader DAWN™ framework, capturing how autoimmune, infection-associated, and overlapping complex chronic conditions evolve across hormonal life stages, environmental exposures, flare patterns, and treatment response.
While DAWN™ models the immune-endocrine terrain at a systems level, The Eve Research Project captures how that terrain is experienced in practice. By tracking longitudinal symptom patterns and contextual factors such as hormonal transition and environmental exposure, it provides visibility into how disease develops, fluctuates, and stabilizes over time.
This distinction is critical. DAWN™ identifies population-level patterns and system intelligence, while The Eve Research Project contributes patient-level trajectory data that helps validate, refine, and operationalize those models. Together, they create a continuous feedback loop between large-scale intelligence and real-world disease behavior.
In this way, the Eve Research Project functions as an early operational bridge between detection and lived experience. It strengthens DAWN™ by making system-level insights more observable, measurable, and actionable across the full disease lifecycle.
The phase 1 of the Eve Research Project begins with the CYNAERA, Invisible Trigger Webinar on June 10, 2026 at 1pm, followed by a 30-day guided tracking phase starting July 8th. It is designed to help the Eve Research Project participants better understand symptom patterns, flare ramps, environmental triggers, sleep disruption, and recovery dynamics. Participants receive personalized, provider-ready reports designed to support more informed clinical conversations and earlier recognition of complex chronic illness patterns.